Involucrin: Difference between revisions
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
m (Bot: HTTP→HTTPS) |
||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
{{ | {{Infobox protein family | ||
| | | Symbol = Involucrin_N | ||
| | | Name = Involucrin of squamous epithelia N-terminus | ||
| | | image = | ||
| | | width = | ||
| | | caption = | ||
| Pfam = PF10583 | |||
| Pfam_clan = | |||
| InterPro = IPR019571 | |||
| SMART = | |||
| PROSITE = | |||
| MEROPS = | |||
| SCOP = | |||
| TCDB = | |||
| OPM family = | |||
| OPM protein = | |||
| CAZy = | |||
| CDD = | |||
}} | }} | ||
{{Infobox protein family | |||
| Symbol = Involucrin | |||
| Name = Involucrin repeat | |||
| image = | |||
| width = | |||
| caption = | |||
| Pfam = PF00904 | |||
| Pfam_clan = | |||
| InterPro = IPR000354 | |||
| SMART = | |||
| PROSITE = | |||
| MEROPS = | |||
| SCOP = 1eu0 | |||
| TCDB = | |||
| OPM family = | |||
| OPM protein = | |||
| CAZy = | |||
| CDD = | |||
}} | |||
{{Infobox protein family | |||
| Symbol = Involucrin2 | |||
| Name = Involucrin repeat | |||
| image = | |||
| width = | |||
| caption = | |||
| Pfam = PF06994 | |||
| Pfam_clan = | |||
| InterPro = IPR009733 | |||
| SMART = | |||
| PROSITE = | |||
| MEROPS = | |||
| SCOP = | |||
| TCDB = | |||
| OPM family = | |||
| OPM protein = | |||
| CAZy = | |||
| CDD = | |||
}} | |||
'''Involucrin''' is a [[protein]] component of human skin and in humans is encoded by the ''IVL'' [[gene]].<ref name="pmid2873896">{{cite journal | vauthors = Eckert RL, Green H | title = Structure and evolution of the human involucrin gene | journal = Cell | volume = 46 | issue = 4 | pages = 583–9 | date = August 1986 | pmid = 2873896 | doi = 10.1016/0092-8674(86)90884-6 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: IVL involucrin| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3713| accessdate = }}</ref> In binding the protein [[loricrin]], involucrin contributes to the formation of a cell envelope that protects [[corneocyte]]s in the skin. | |||
== Gene == | |||
This gene is mapped to 1q21, among [[S100A10|calpactin]] I light chain, [[TCHH|trichohyalin]], [[profillaggrin]], [[loricrin]], and [[calcyclin]].<ref name="entrez"/> | |||
== Function == | |||
Involucrin is a highly reactive, soluble, [[transglutaminase]] [[Enzyme substrate|substrate]] [[protein]] present in [[keratinocytes]] of [[Epidermis (skin)|epidermis]] and other [[stratified squamous epithelia]].<ref name="pmid1359382">{{cite journal | vauthors = Green H, Djian P | title = Consecutive actions of different gene-altering mechanisms in the evolution of involucrin | journal = Molecular Biology and Evolution | volume = 9 | issue = 6 | pages = 977–1017 | date = November 1992 | pmid = 1359382 | url = http://mbe.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=1359382 }}</ref><ref name="pmid8277848">{{cite journal | vauthors = Djian P, Phillips M, Easley K, Huang E, Simon M, Rice RH, Green H | title = The involucrin genes of the mouse and the rat: study of their shared repeats | journal = Molecular Biology and Evolution | volume = 10 | issue = 6 | pages = 1136–49 | date = November 1993 | pmid = 8277848 | url = http://mbe.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=8277848 }}</ref> It first appears in the [[Cell (biology)|cell]] [[cytosol]], but ultimately becomes cross-linked to [[membrane proteins]] by transglutaminase thus helping in the formation of an insoluble envelope beneath the [[Cell membrane|plasma membrane]] functioning as a [[glutamyl]] donor during assembly of the cornified envelope.<ref name="pmid8098344">{{cite journal | vauthors = Eckert RL, Yaffe MB, Crish JF, Murthy S, Rorke EA, Welter JF | title = Involucrin--structure and role in envelope assembly | journal = The Journal of Investigative Dermatology | volume = 100 | issue = 5 | pages = 613–7 | date = May 1993 | pmid = 8098344 | doi = 10.1111/1523-1747.ep12472288 }}</ref> | |||
Involucrin is synthesised in the [[stratum spinosum]] and cross linked in the [[stratum granulosum]] by the [[transglutaminase]] enzyme that makes it highly stable. Thus it provides structural support to the cell, thereby allowing the cell to resist invasion by micro-organisms.{{citation needed|date=January 2017}} | |||
[[Apigenin]], a plant-derived [[flavanoid]] that has significant promise as a [[skin cancer]] [[chemopreventive]] agent, has been found to regulate normal [[Homo sapiens|human]] keratinocyte [[differentiation (cellular)|differentiation]] by suppressing involucrin, and this is associated with reduced cell proliferation without [[apoptosis]].<ref name="pmid16982614">{{cite journal | vauthors = Balasubramanian S, Zhu L, Eckert RL | title = Apigenin inhibition of involucrin gene expression is associated with a specific reduction in phosphorylation of protein kinase Cdelta Tyr311 | journal = The Journal of Biological Chemistry | volume = 281 | issue = 47 | pages = 36162–72 | date = November 2006 | pmid = 16982614 | doi = 10.1074/jbc.M605368200 }}</ref> | |||
{{ | |||
== Clinical significance == | |||
As one of the precursor proteins of the cornified cell envelope, involucrin is markedly increased in inflammatory skin diseases such as psoriasis<ref>{{cite journal | vauthors = Takahashi H, Hashimoto Y, Ishida-Yamamoto A, Iizuka H | title = Roxithromycin suppresses involucrin expression by modulation of activator protein-1 and nuclear factor-kappaB activities of keratinocytes | journal = Journal of Dermatological Science | volume = 39 | issue = 3 | pages = 175–82 | date = September 2005 | pmid = 16140218 | doi = 10.1016/j.jdermsci.2005.03.006 }}</ref> | |||
[[Lamellar ichthyosis]] involves a decrease in expression of involucrin. This decrease could contribute to the altered desquamation process seen in the disease, since the clinical improvement associated with retinoid treatment is accompanied by increased expression of involucrin.<ref>{{cite journal | vauthors = Peña-Penabad C, de Unamuno P, García Silva J, Ludeña MD, González Sarmiento R, Pérez-Arellano JL | title = Altered expression of immunoreactive involucrin in lamellar ichthyosis | journal = European Journal of Dermatology | volume = 9 | issue = 3 | pages = 197–201 | year = 1999 | pmid = 10210784 | url = http://www.john-libbey-eurotext.fr/medline.md?issn=1167-1122&vol=9&iss=3&page=197 }}</ref> | |||
==Structure== | |||
Involucrin consists of a [[conserved sequence|conserved]] [[N-terminal]] region of about 75 [[amino acid]] residues followed by two extremely variable length segments that contain [[glutamine]]-rich [[tandem repeats]]. The [[glutamine]] residues in the tandem repeats are the [[Substrate (biochemistry)|substrate]] for the transglutaminase in the cross-linking reaction. The total size of the protein varies from 285 residues (in [[dog]]) to 835 residues (in [[orangutan]]).{{citation needed|date=January 2017}} | |||
== References == | |||
{{reflist}} | |||
}} | |||
== Further reading == | |||
==Further reading== | |||
{{refbegin | 2}} | {{refbegin | 2}} | ||
* {{cite journal | vauthors = Eckert RL, Crish JF, Efimova T, Dashti SR, Deucher A, Bone F, Adhikary G, Huang G, Gopalakrishnan R, Balasubramanian S | title = Regulation of involucrin gene expression | journal = The Journal of Investigative Dermatology | volume = 123 | issue = 1 | pages = 13–22 | date = July 2004 | pmid = 15191537 | doi = 10.1111/j.0022-202X.2004.22723.x }} | |||
* {{cite journal | vauthors = Rice RH, Green H | title = Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions | journal = Cell | volume = 18 | issue = 3 | pages = 681–94 | date = November 1979 | pmid = 42494 | doi = 10.1016/0092-8674(79)90123-5 }} | |||
*{{cite journal | * {{cite journal | vauthors = Yaffe MB, Beegen H, Eckert RL | title = Biophysical characterization of involucrin reveals a molecule ideally suited to function as an intermolecular cross-bridge of the keratinocyte cornified envelope | journal = The Journal of Biological Chemistry | volume = 267 | issue = 17 | pages = 12233–8 | date = June 1992 | pmid = 1601889 | url = http://www.jbc.org/cgi/pmidlookup?view=long&pmid=1601889 }} | ||
*{{cite journal | * {{cite journal | vauthors = Simon M, Green H | title = The glutamine residues reactive in transglutaminase-catalyzed cross-linking of involucrin | journal = The Journal of Biological Chemistry | volume = 263 | issue = 34 | pages = 18093–8 | date = December 1988 | pmid = 2461365 | url = http://www.jbc.org/cgi/pmidlookup?view=long&pmid=2461365 }} | ||
*{{cite journal | * {{cite journal | vauthors = Heller M, Flemington E, Kieff E, Deininger P | title = Repeat arrays in cellular DNA related to the Epstein-Barr virus IR3 repeat | journal = Molecular and Cellular Biology | volume = 5 | issue = 3 | pages = 457–65 | date = March 1985 | pmid = 2985954 | pmc = 366737 | url = http://mcb.asm.org/cgi/pmidlookup?view=long&pmid=2985954 | doi=10.1128/mcb.5.3.457}} | ||
*{{cite journal | * {{cite journal | vauthors = Welter JF, Crish JF, Agarwal C, Eckert RL | title = Fos-related antigen (Fra-1), junB, and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity | journal = The Journal of Biological Chemistry | volume = 270 | issue = 21 | pages = 12614–22 | date = May 1995 | pmid = 7759510 | doi = 10.1074/jbc.270.21.12614 }} | ||
*{{cite journal | * {{cite journal | vauthors = Volz A, Korge BP, Compton JG, Ziegler A, Steinert PM, Mischke D | title = Physical mapping of a functional cluster of epidermal differentiation genes on chromosome 1q21 | journal = Genomics | volume = 18 | issue = 1 | pages = 92–9 | date = October 1993 | pmid = 8276421 | doi = 10.1006/geno.1993.1430 }} | ||
*{{cite journal | * {{cite journal | vauthors = Takahashi H, Iizuka H | title = Analysis of the 5'-upstream promoter region of human involucrin gene: activation by 12-O-tetradecanoylphorbol-13-acetate | journal = The Journal of Investigative Dermatology | volume = 100 | issue = 1 | pages = 10–5 | date = January 1993 | pmid = 8380829 | doi = 10.1111/1523-1747.ep12349867 }} | ||
*{{cite journal | * {{cite journal | vauthors = Lopez-Bayghen E, Vega A, Cadena A, Granados SE, Jave LF, Gariglio P, Alvarez-Salas LM | title = Transcriptional analysis of the 5'-noncoding region of the human involucrin gene | journal = The Journal of Biological Chemistry | volume = 271 | issue = 1 | pages = 512–20 | date = January 1996 | pmid = 8550612 | doi = 10.1074/jbc.271.1.512 }} | ||
* {{cite journal | vauthors = Takahashi H, Kobayashi H, Matsuo S, Iizuka H | title = Repression of involucrin gene expression by transcriptional enhancer factor 1 (TEF-1) | journal = Archives of Dermatological Research | volume = 287 | issue = 8 | pages = 740–6 | year = 1995 | pmid = 8554386 | doi = 10.1007/BF01105799 }} | |||
*{{cite journal | * {{cite journal | vauthors = Steinert PM, Marekov LN | title = Direct evidence that involucrin is a major early isopeptide cross-linked component of the keratinocyte cornified cell envelope | journal = The Journal of Biological Chemistry | volume = 272 | issue = 3 | pages = 2021–30 | date = January 1997 | pmid = 8999895 | doi = 10.1074/jbc.272.3.2021 }} | ||
*{{cite journal | * {{cite journal | vauthors = Robinson NA, Lapic S, Welter JF, Eckert RL | title = S100A11, S100A10, annexin I, desmosomal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes | journal = The Journal of Biological Chemistry | volume = 272 | issue = 18 | pages = 12035–46 | date = May 1997 | pmid = 9115270 | doi = 10.1074/jbc.272.18.12035 }} | ||
*{{cite journal | * {{cite journal | vauthors = Ng DC, Su MJ, Kim R, Bikle DD | title = Regulation of involucrin gene expression by calcium in normal human keratinocytes | journal = Frontiers in Bioscience | volume = 1 | pages = a16-24 | date = January 1996 | pmid = 9159190 | doi = 10.2741/A101 }} | ||
*{{cite journal | * {{cite journal | vauthors = Banks EB, Crish JF, Welter JF, Eckert RL | title = Characterization of human involucrin promoter distal regulatory region transcriptional activator elements-a role for Sp1 and AP1 binding sites | journal = The Biochemical Journal | volume = 331 | issue = 1 | pages = 61–8 | date = April 1998 | pmid = 9512462 | pmc = 1219321 | url = http://www.biochemj.org/cgi/pmidlookup?view=long&pmid=9512462 | doi=10.1042/bj3310061}} | ||
*{{cite journal | * {{cite journal | vauthors = Marekov LN, Steinert PM | title = Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope | journal = The Journal of Biological Chemistry | volume = 273 | issue = 28 | pages = 17763–70 | date = July 1998 | pmid = 9651377 | doi = 10.1074/jbc.273.28.17763 }} | ||
* {{cite journal | vauthors = Crish JF, Zaim TM, Eckert RL | title = The distal regulatory region of the human involucrin promoter is required for expression in epidermis | journal = The Journal of Biological Chemistry | volume = 273 | issue = 46 | pages = 30460–5 | date = November 1998 | pmid = 9804813 | doi = 10.1074/jbc.273.46.30460 }} | |||
*{{cite journal | * {{cite journal | vauthors = Lee CH, Marekov LN, Kim S, Brahim JS, Park MH, Steinert PM | title = Small proline-rich protein 1 is the major component of the cell envelope of normal human oral keratinocytes | journal = FEBS Letters | volume = 477 | issue = 3 | pages = 268–72 | date = July 2000 | pmid = 10908733 | doi = 10.1016/S0014-5793(00)01806-8 }} | ||
*{{cite journal | * {{cite journal | vauthors = Candi E, Oddi S, Terrinoni A, Paradisi A, Ranalli M, Finazzi-Agró A, Melino G | title = Transglutaminase 5 cross-links loricrin, involucrin, and small proline-rich proteins in vitro | journal = The Journal of Biological Chemistry | volume = 276 | issue = 37 | pages = 35014–23 | date = September 2001 | pmid = 11443109 | doi = 10.1074/jbc.M010157200 }} | ||
* {{cite journal | vauthors = Crish JF, Bone F, Banks EB, Eckert RL | title = The human involucrin gene contains spatially distinct regulatory elements that regulate expression during early versus late epidermal differentiation | journal = Oncogene | volume = 21 | issue = 5 | pages = 738–47 | date = January 2002 | pmid = 11850802 | doi = 10.1038/sj.onc.1205038 }} | |||
*{{cite journal | |||
*{{cite journal | |||
}} | |||
{{refend}} | {{refend}} | ||
{{ | {{InterPro content|IPR019571}} | ||
[[Category:Protein domains]] |
Latest revision as of 06:55, 1 September 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Involucrin of squamous epithelia N-terminus | |||||||||
---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||
Symbol | Involucrin_N | ||||||||
Pfam | PF10583 | ||||||||
InterPro | IPR019571 | ||||||||
|
Involucrin repeat | |||||||||
---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||
Symbol | Involucrin | ||||||||
Pfam | PF00904 | ||||||||
InterPro | IPR000354 | ||||||||
SCOP | 1eu0 | ||||||||
SUPERFAMILY | 1eu0 | ||||||||
|
Involucrin repeat | |||||||||
---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||
Symbol | Involucrin2 | ||||||||
Pfam | PF06994 | ||||||||
InterPro | IPR009733 | ||||||||
|
Involucrin is a protein component of human skin and in humans is encoded by the IVL gene.[1][2] In binding the protein loricrin, involucrin contributes to the formation of a cell envelope that protects corneocytes in the skin.
Gene
This gene is mapped to 1q21, among calpactin I light chain, trichohyalin, profillaggrin, loricrin, and calcyclin.[2]
Function
Involucrin is a highly reactive, soluble, transglutaminase substrate protein present in keratinocytes of epidermis and other stratified squamous epithelia.[3][4] It first appears in the cell cytosol, but ultimately becomes cross-linked to membrane proteins by transglutaminase thus helping in the formation of an insoluble envelope beneath the plasma membrane functioning as a glutamyl donor during assembly of the cornified envelope.[5]
Involucrin is synthesised in the stratum spinosum and cross linked in the stratum granulosum by the transglutaminase enzyme that makes it highly stable. Thus it provides structural support to the cell, thereby allowing the cell to resist invasion by micro-organisms.[citation needed]
Apigenin, a plant-derived flavanoid that has significant promise as a skin cancer chemopreventive agent, has been found to regulate normal human keratinocyte differentiation by suppressing involucrin, and this is associated with reduced cell proliferation without apoptosis.[6]
Clinical significance
As one of the precursor proteins of the cornified cell envelope, involucrin is markedly increased in inflammatory skin diseases such as psoriasis[7]
Lamellar ichthyosis involves a decrease in expression of involucrin. This decrease could contribute to the altered desquamation process seen in the disease, since the clinical improvement associated with retinoid treatment is accompanied by increased expression of involucrin.[8]
Structure
Involucrin consists of a conserved N-terminal region of about 75 amino acid residues followed by two extremely variable length segments that contain glutamine-rich tandem repeats. The glutamine residues in the tandem repeats are the substrate for the transglutaminase in the cross-linking reaction. The total size of the protein varies from 285 residues (in dog) to 835 residues (in orangutan).[citation needed]
References
- ↑ Eckert RL, Green H (August 1986). "Structure and evolution of the human involucrin gene". Cell. 46 (4): 583–9. doi:10.1016/0092-8674(86)90884-6. PMID 2873896.
- ↑ 2.0 2.1 "Entrez Gene: IVL involucrin".
- ↑ Green H, Djian P (November 1992). "Consecutive actions of different gene-altering mechanisms in the evolution of involucrin". Molecular Biology and Evolution. 9 (6): 977–1017. PMID 1359382.
- ↑ Djian P, Phillips M, Easley K, Huang E, Simon M, Rice RH, Green H (November 1993). "The involucrin genes of the mouse and the rat: study of their shared repeats". Molecular Biology and Evolution. 10 (6): 1136–49. PMID 8277848.
- ↑ Eckert RL, Yaffe MB, Crish JF, Murthy S, Rorke EA, Welter JF (May 1993). "Involucrin--structure and role in envelope assembly". The Journal of Investigative Dermatology. 100 (5): 613–7. doi:10.1111/1523-1747.ep12472288. PMID 8098344.
- ↑ Balasubramanian S, Zhu L, Eckert RL (November 2006). "Apigenin inhibition of involucrin gene expression is associated with a specific reduction in phosphorylation of protein kinase Cdelta Tyr311". The Journal of Biological Chemistry. 281 (47): 36162–72. doi:10.1074/jbc.M605368200. PMID 16982614.
- ↑ Takahashi H, Hashimoto Y, Ishida-Yamamoto A, Iizuka H (September 2005). "Roxithromycin suppresses involucrin expression by modulation of activator protein-1 and nuclear factor-kappaB activities of keratinocytes". Journal of Dermatological Science. 39 (3): 175–82. doi:10.1016/j.jdermsci.2005.03.006. PMID 16140218.
- ↑ Peña-Penabad C, de Unamuno P, García Silva J, Ludeña MD, González Sarmiento R, Pérez-Arellano JL (1999). "Altered expression of immunoreactive involucrin in lamellar ichthyosis". European Journal of Dermatology. 9 (3): 197–201. PMID 10210784.
Further reading
- Eckert RL, Crish JF, Efimova T, Dashti SR, Deucher A, Bone F, Adhikary G, Huang G, Gopalakrishnan R, Balasubramanian S (July 2004). "Regulation of involucrin gene expression". The Journal of Investigative Dermatology. 123 (1): 13–22. doi:10.1111/j.0022-202X.2004.22723.x. PMID 15191537.
- Rice RH, Green H (November 1979). "Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions". Cell. 18 (3): 681–94. doi:10.1016/0092-8674(79)90123-5. PMID 42494.
- Yaffe MB, Beegen H, Eckert RL (June 1992). "Biophysical characterization of involucrin reveals a molecule ideally suited to function as an intermolecular cross-bridge of the keratinocyte cornified envelope". The Journal of Biological Chemistry. 267 (17): 12233–8. PMID 1601889.
- Simon M, Green H (December 1988). "The glutamine residues reactive in transglutaminase-catalyzed cross-linking of involucrin". The Journal of Biological Chemistry. 263 (34): 18093–8. PMID 2461365.
- Heller M, Flemington E, Kieff E, Deininger P (March 1985). "Repeat arrays in cellular DNA related to the Epstein-Barr virus IR3 repeat". Molecular and Cellular Biology. 5 (3): 457–65. doi:10.1128/mcb.5.3.457. PMC 366737. PMID 2985954.
- Welter JF, Crish JF, Agarwal C, Eckert RL (May 1995). "Fos-related antigen (Fra-1), junB, and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity". The Journal of Biological Chemistry. 270 (21): 12614–22. doi:10.1074/jbc.270.21.12614. PMID 7759510.
- Volz A, Korge BP, Compton JG, Ziegler A, Steinert PM, Mischke D (October 1993). "Physical mapping of a functional cluster of epidermal differentiation genes on chromosome 1q21". Genomics. 18 (1): 92–9. doi:10.1006/geno.1993.1430. PMID 8276421.
- Takahashi H, Iizuka H (January 1993). "Analysis of the 5'-upstream promoter region of human involucrin gene: activation by 12-O-tetradecanoylphorbol-13-acetate". The Journal of Investigative Dermatology. 100 (1): 10–5. doi:10.1111/1523-1747.ep12349867. PMID 8380829.
- Lopez-Bayghen E, Vega A, Cadena A, Granados SE, Jave LF, Gariglio P, Alvarez-Salas LM (January 1996). "Transcriptional analysis of the 5'-noncoding region of the human involucrin gene". The Journal of Biological Chemistry. 271 (1): 512–20. doi:10.1074/jbc.271.1.512. PMID 8550612.
- Takahashi H, Kobayashi H, Matsuo S, Iizuka H (1995). "Repression of involucrin gene expression by transcriptional enhancer factor 1 (TEF-1)". Archives of Dermatological Research. 287 (8): 740–6. doi:10.1007/BF01105799. PMID 8554386.
- Steinert PM, Marekov LN (January 1997). "Direct evidence that involucrin is a major early isopeptide cross-linked component of the keratinocyte cornified cell envelope". The Journal of Biological Chemistry. 272 (3): 2021–30. doi:10.1074/jbc.272.3.2021. PMID 8999895.
- Robinson NA, Lapic S, Welter JF, Eckert RL (May 1997). "S100A11, S100A10, annexin I, desmosomal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes". The Journal of Biological Chemistry. 272 (18): 12035–46. doi:10.1074/jbc.272.18.12035. PMID 9115270.
- Ng DC, Su MJ, Kim R, Bikle DD (January 1996). "Regulation of involucrin gene expression by calcium in normal human keratinocytes". Frontiers in Bioscience. 1: a16–24. doi:10.2741/A101. PMID 9159190.
- Banks EB, Crish JF, Welter JF, Eckert RL (April 1998). "Characterization of human involucrin promoter distal regulatory region transcriptional activator elements-a role for Sp1 and AP1 binding sites". The Biochemical Journal. 331 (1): 61–8. doi:10.1042/bj3310061. PMC 1219321. PMID 9512462.
- Marekov LN, Steinert PM (July 1998). "Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope". The Journal of Biological Chemistry. 273 (28): 17763–70. doi:10.1074/jbc.273.28.17763. PMID 9651377.
- Crish JF, Zaim TM, Eckert RL (November 1998). "The distal regulatory region of the human involucrin promoter is required for expression in epidermis". The Journal of Biological Chemistry. 273 (46): 30460–5. doi:10.1074/jbc.273.46.30460. PMID 9804813.
- Lee CH, Marekov LN, Kim S, Brahim JS, Park MH, Steinert PM (July 2000). "Small proline-rich protein 1 is the major component of the cell envelope of normal human oral keratinocytes". FEBS Letters. 477 (3): 268–72. doi:10.1016/S0014-5793(00)01806-8. PMID 10908733.
- Candi E, Oddi S, Terrinoni A, Paradisi A, Ranalli M, Finazzi-Agró A, Melino G (September 2001). "Transglutaminase 5 cross-links loricrin, involucrin, and small proline-rich proteins in vitro". The Journal of Biological Chemistry. 276 (37): 35014–23. doi:10.1074/jbc.M010157200. PMID 11443109.
- Crish JF, Bone F, Banks EB, Eckert RL (January 2002). "The human involucrin gene contains spatially distinct regulatory elements that regulate expression during early versus late epidermal differentiation". Oncogene. 21 (5): 738–47. doi:10.1038/sj.onc.1205038. PMID 11850802.